| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.88▲ | 2.87▲ | 2.86▲ | 2.82▲ | 2.70▲ |
| MA10 | 2.87▲ | 2.78▲ | 2.73▲ | 2.89▲ | 3.55▼ |
| MA20 | 2.78▲ | 2.69▲ | 2.73▲ | 2.81▲ | 3.13▼ |
| MA50 | 2.67▲ | 2.85▲ | 2.88▲ | 3.58▼ | 2.99▼ |
| MA100 | 2.71▲ | 2.87▲ | 2.72▲ | 3.11▼ | 2.81▲ |
| MA200 | 2.86▲ | 2.74▲ | 3.24▼ | 3.00▼ | 3.49▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.008▲ | 0.041▲ | 0.036▲ | 0.033▲ | -0.110▼ |
| RSI | 74.473▲ | 61.573▲ | 57.098▲ | 45.398▼ | 48.048▼ |
| STOCH | 90.909▲ | 96.825▲ | 88.100▲ | 47.924 | 15.364▼ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -46.341 | -83.212▼ |
| CCI | 83.333 | 90.829 | 114.280▲ | 24.549 | -56.072 |
|
Tuesday, March 31, 2020 04:20 AM
NEW YORK, March 31, Mar 31, 2020 (GLOBE NEWSWIRE via COMTEX) -- NEW YORK, March 31, 2020 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company ...
|
|
Tuesday, March 31, 2020 04:20 AM
Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and ...
|
|
Tuesday, March 31, 2020 04:10 AM
NEW YORK, March 31, 2020 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/04/20 | 2.75 | 2.89 | 2.75 | 2.89 | 612,280 |
| 03/04/20 | 2.64 | 2.68 | 2.53 | 2.62 | 566,700 |
| 02/04/20 | 2.79 | 2.83 | 2.58 | 2.63 | 917,981 |
| 01/04/20 | 3.04 | 3.11 | 2.81 | 2.82 | 1,093,900 |
| 31/03/20 | 3.02 | 3.46 | 2.92 | 3.15 | 2,086,100 |
| 30/03/20 | 2.90 | 3.02 | 2.675 | 3.01 | 1,135,000 |
| 27/03/20 | 2.90 | 3.01 | 2.76 | 2.92 | 647,400 |
| 26/03/20 | 2.88 | 3.07 | 2.819 | 2.98 | 1,058,500 |
| 25/03/20 | 2.98 | 3.16 | 2.77 | 2.89 | 656,300 |
| 24/03/20 | 3.02 | 3.08 | 2.65 | 2.99 | 1,062,700 |
|
|
||||
|
|
||||
|
|